Your browser doesn't support javascript.
loading
APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancer.
Garcia, Nina Marie G; Becerra, Jessica N; McKinney, Brock J; DiMarco, Ashley V; Wu, Feinan; Fitzgibbon, Matthew; Alvarez, James V.
Affiliation
  • Garcia NMG; Translational Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Center.
  • Becerra JN; Department of Pharmacology and Cancer Biology, Duke University School of Medicine.
  • McKinney BJ; Translational Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Center.
  • DiMarco AV; Translational Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Center.
  • Wu F; Department of Pharmacology and Cancer Biology, Duke University School of Medicine.
  • Fitzgibbon M; Genomics and Bioinformatics, Fred Hutchinson Cancer Center.
  • Alvarez JV; Genomics and Bioinformatics, Fred Hutchinson Cancer Center.
bioRxiv ; 2023 Jul 03.
Article de En | MEDLINE | ID: mdl-37461590
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: BioRxiv Année: 2023 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: BioRxiv Année: 2023 Type de document: Article